期刊文献+

肾康注射液对大鼠腹膜透析功能及氧化应激的影响 被引量:7

The Effect of Shen Kang Injection on Peritoneal Dialysis and Oxidative Stress in Rats
暂未订购
导出
摘要 目的:研究肾康注射液(SKI)对腹膜透析液(peritoneal dialysis solution,PDS)诱导的大鼠腹膜透析功能减退及氧化应激的影响。方法:50只SD大鼠,随机分为正常对照组、4.25%PDS组和SKI低、中、高剂量(SKI组都加入4.25%PDS)组,8周后进行腹膜功能实验,量取透出液体积,腹主动脉取血检测血清中的超氧化物歧化酶(SOD)、丙二醛(MDA)的含量,并计算超滤量(UF)、葡萄糖转运量(MTG)及葡萄糖清除率(C)。结果:与PDS组比较,SKI中、高剂量组的UF、C、SOD含量显著增加(P<0.05),SKI各剂量组的MTG、MDA含量显著下降(P<0.05)。结论:腹膜透析液中加入SKI具有改善PDS诱导的腹膜透析功能减退和抑制氧化应激的作用。 Objective: To investigate the influence of Shen Kang injection (SKI) on decrease of peritoneal dialysis effect caused by peritoneal dialysis solution (PDS) and oxidative stress in rats. Methods: Fifty SD rats were randomly divided into normal control group, 4.25% PDS group, and groups of 4.25% PDS + low, moderate and high doses of SKI respectively. Peritoneal function test was performed in rats of each group in 8 weeks after intraperitoneal injection with PDS or/and SKI. The volume of peritoneal effluent was detected, and blood samples were taken from abdominal aorta. Serum levels of superoxide dismutase ( SOD), malondialdehyde (MDA) were measured. Ultrafihratian amount (UF), mass transfer amount of glucose '(MTG) and clearance rates of glucose (C) were detected. Results: UF, C and serum levels of SOD in SKI groups were higher than those in group PDS (P 〈 0.05). Serum levels of MDA and MTG in SKI groups were lower than those in group PDS (P 〈 0. 05). Conclusions: SKI may be helpful in ameliorating peritoneal dialysis function decrease caused by PDS and inhibiting oxidative stress in peritoneal dialysis rats.
出处 《贵阳医学院学报》 CAS 2013年第2期138-140,共3页 Journal of Guiyang Medical College
基金 贵州省科学技术基金项目(黔科合J字[2011]2252号)
关键词 腹膜透析 肾康注射液 氧化性应激 超氧化物歧化酶 丙二醛 peritoneal dialysis Shen Kang injection oxidative stress
  • 相关文献

参考文献9

  • 1Nakamoto H, Kawaguchi Y, Suzuki H. Is technique sur- vivalon peritoneal dialysis better in Japan [ J 1- Petit Dial Int,2006(2) : 1136 - 1140.
  • 2朱志永,凌光辉,刘伏友.腹膜透析超滤衰竭研究进展[J].中国血液净化,2011,10(2):97-99. 被引量:5
  • 3范军.肾康注射液治疗慢性肾功能衰竭临床疗效观察[J].医学信息(中旬刊),2011,24(2):635-636. 被引量:32
  • 4张福港,李晓东,卞书森.肾康注射液在慢性肾衰竭中的治疗作用[J].中国中西医结合肾病杂志,2006,7(7):421-422. 被引量:22
  • 5Lo WK. Peritoneal dialysis utilization and outcome: what are we facing. Peritoneal Dialysis International,2007 (2) : 42-47.
  • 6Kaneko K, Hamada C, Tomino Y. Peritoneal fibrosis in- tervention [ J ]. Peritoneal Dialysis International, 2007 (2) :82 -86.
  • 7Diaz Buxo JA, Gofloib L. Agents that modulate peritoneal membrane structure and function [ J]. Peritoneal Dialysis International, 2007 (27) : 16.
  • 8Noh H, Kim js, Hart KH, et al. Oxidative stress, during peritoneal dialysis:implications in functional and structur- al changes in the membrane [ J ]. Kidney International, 2006 ( 11 ) : 2022 - 2028.
  • 9Gunal AI, Celiker H, Ustundag B, et al. The effect of oxidative stress inhibition with trimetazidine on the perito- neal alterations induced by hypertonie peritoneal dialysis solution [ J ]. Journal of Nephrology,2003 (2) :225 - 230.

二级参考文献51

共引文献54

同被引文献64

  • 1王立红,刘玉宁,郭立中.肾康注射液对糖尿病肾病大鼠细胞外基质影响的实验研究[J].中国中医药科技,2005,12(2):77-78. 被引量:7
  • 2夏天,苏如松,赵爱国,李荣,康莉.丹参对CAPD大鼠腹膜间皮细胞凋亡及凋亡相关基因的影响[J].天津医药,2005,33(5):284-286. 被引量:9
  • 3Brenner BM, Cooper ME, de Zeeuw DK, et al, Effects If Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N Engl Mngl J Med.2001, 345:861-869.
  • 4Nakamoto H, Kawaguchi Y, Suzuki H. ls technique survivalon peri|oneal dialysis better in Japan [ J ]. PeritDial hat, 2006,26(2) :1136-1139.
  • 5Lo W K. Peritoneal dialysis utilization and outcome: what are we facing [Jl. Perit Dial Int,2007,27 (2): 42 -44.
  • 6Izumotani T, lshimura E, Yamamoto T, et al. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patient s on continuous ambulatory peritoneal dialysis [J]. Nephron,2001,89 (1):43-49.
  • 7Kaneko K, Hamada C, Tomino Y. Peritoneal fibrosis intervention [ J ]. Perit Dial lnt, 2007, 27 ( 2 ) :82-87.
  • 8Diaz Buxo J A, Gotloib L. Agents that modulate peritoneal membrane structure and function [ J ]. Perit Dial Int, 2007,27( 1 ) :16-30.
  • 9Margetts P cytokines, peritoneum 2285 -2294 J, Kolb M, Yu L, et al. angiogenesis, and fibrosis J Pathol, 2002, Inflammatory in the rat 160 (6):2285-2294.
  • 10崔俊起,韩平杰.肾康注射液对早期糖尿病肾病的治疗观察[J].中国误诊学杂志,2008,8(9):2096-2097. 被引量:27

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部